William Lis
2015 - Portola Pharmaceuticals
In 2015, William Lis earned a total compensation of $5.5M as Chief Executive Officer at Portola Pharmaceuticals, a 65% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $315,000 |
|---|---|
| Option Awards | $2,321,917 |
| Salary | $500,000 |
| Stock Awards | $2,356,250 |
| Other | $23,032 |
| Total | $5,516,199 |
Lis received $2.4M in stock awards, accounting for 43% of the total pay in 2015.
Lis also received $315K in non-equity incentive plan, $2.3M in option awards, $500K in salary and $23K in other compensation.
Rankings
In 2015, William Lis' compensation ranked 1,402nd out of 13,638 executives tracked by ExecPay. In other words, Lis earned more than 89.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,402 out of 13,638 | 90th |
Division Manufacturing | 490 out of 5,190 | 91st |
Major group Chemicals And Allied Products | 181 out of 1,854 | 90th |
Industry group Drugs | 139 out of 1,528 | 91st |
Industry Pharmaceutical Preparations | 114 out of 1,182 | 90th |
Source: SEC filing on April 24, 2017.
Lis' colleagues
We found three more compensation records of executives who worked with William Lis at Portola Pharmaceuticals in 2015.